← Open Payments lookup

REBECCA ELLSPERMANN: Open Payments

NPI 1083857429 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,029 in 129 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $2,174 · 2025 $3,029

Food & beverage: $2,731Education: $299
CompanyPaymentsAmount
GENZYME CORPORATION13$419
ABBVIE INC.26$407
Regeneron Healthcare Solutions, Inc.13$370
UCB, Inc.17$362
Galderma Laboratories, L.P.17$251
Janssen Biotech, Inc.5$240
Novartis Pharmaceuticals Corporation9$188
E.R. Squibb & Sons, L.L.C.6$183
Arcutis Biotherapeutics, Inc.1$122
SANOFI-AVENTIS U.S. LLC1$99

Products named: DUPIXENT, Bimzelx, NEMLUVIO, RINVOQ, TREMFYA, Sotyktu, SKYRIZI, Zoryve.

Industry payments across TX — which companies pay providers there.